Valuation: Amneal Pharmaceuticals, Inc.

Market Cap 6.79B 5.96B 5.6B 5.12B 9.57B 651B 9.64B 67.31B 26.09B 332B 25.51B 24.95B 1,075B P/E 2026 *
39.8x
P/E 2027 * 24.3x
Enterprise Value 9.11B 8B 7.52B 6.87B 12.84B 873B 12.94B 90.27B 35B 445B 34.21B 33.46B 1,442B EV / Sales 2026 *
2.89x
EV / Sales 2027 * 2.56x
Free-Float
44.36%
Yield 2026 *
-
Yield 2027 * -
1 day-3.51%
1 week+3.71%
Current month+7.33%
1 month+5.46%
3 months+12.55%
6 months+57.30%
Current year+48.81%
1 week 18.06
Extreme 18.06
21.18
1 month 16.56
Extreme 16.56
21.18
Current year 11.71
Extreme 11.71
21.18
1 year 9.49
Extreme 9.49
21.18
3 years 3.36
Extreme 3.36
21.18
5 years 1.24
Extreme 1.24
21.18
10 years 1.24
Extreme 1.24
24.48
Manager TitleAgeSince
Chief Executive Officer 59 01/08/2019
Chief Executive Officer 54 01/08/2019
Director of Finance/CFO 58 07/11/2023
Director TitleAgeSince
Director/Board Member 59 07/11/2023
Director/Board Member 70 07/11/2023
Director/Board Member 52 07/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/09/26 Don

Director

-20,445 0.0064%
11/09/26 Exercice

Director

40,890 0.0128%
01/09/26 Don

Executive/Senior Manager

-80,000 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
-3.49%+3.71%+90.55%+348.56% 6.79B
-1.86%+0.97%+53.80%+108.02% 1,043B
-0.53%+0.28%+51.78%+67.24% 649B
-0.28%+0.90%+18.99%+71.27% 469B
-0.25%+0.19%+36.95%+45.54% 355B
+0.98%+2.91%+20.59%+27.14% 270B
-1.91%+2.42%+10.41%+11.04% 262B
-0.92%+8.00%+41.72%+52.32% 222B
-1.50%+1.95%+31.61%+101.21% 189B
-2.53%-7.47%-32.63%-60.41% 175B
Average -1.17%+3.69%+32.38%+77.19% 363.98B
Weighted average by Cap. -0.96%+2.21%+35.75%+65.55%

Financials

2026 *2027 *
Net sales 3.15B 2.77B 2.6B 2.38B 4.45B 302B 4.48B 31.26B 12.12B 154B 11.84B 11.58B 499B 3.44B 3.02B 2.84B 2.59B 4.85B 329B 4.88B 34.08B 13.21B 168B 12.91B 12.63B 544B
Net income 165M 145M 136M 125M 233M 15.84B 235M 1.64B 635M 8.08B 621M 608M 26.19B 274M 241M 226M 207M 386M 26.26B 389M 2.72B 1.05B 13.39B 1.03B 1.01B 43.42B
Net Debt 2.32B 2.03B 1.91B 1.75B 3.27B 222B 3.29B 22.97B 8.9B 113B 8.7B 8.51B 367B 2B 1.75B 1.65B 1.51B 2.81B 191B 2.83B 19.77B 7.67B 97.44B 7.49B 7.33B 316B
Logo Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Employees
8,700
Date Price Change Volume
23/09/26 $18.75 -3.85% 1,901,474
22/09/26 $19.50 -3.27% 2,481,387
21/09/26 $20.16 +7.75% 5,908,094
18/09/26 $18.71 +2.35% 6,619,091
17/09/26 $18.28 +1.11% 2,816,756
Trader
Investor
Global
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
19.50USD
Average target price
22.00USD
Spread / Average Target
+12.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!